J&J, world's largest drugmaker, plans to split in two

Johnson & Johnson, the world's largest drugmaker and one of its oldest, is splitting in two in a major corporate shake-up that's meant to boost the value of the company's main businesses.

On Friday, J&J said it will separate its consumer health division, which sells well-known brands like Tylenol, Listerine, and Band-Aids, into a new publicly traded company. The top executives of the yet-to-be-named company will be "determined and announced in due course" as the separation progresses, J&J said.